glp-1 non-diabetic weight loss effectiveness Only a few week old (2026 jan 22) systematic review revealed that agonists have the greatest benefit for younger female patients. https://diabetesjournals.org/care/article/48/2/292/157724/Efficacy -of-GLP-1-Receptor-Agonists-on-Weight Comparative effectiveness of GLP-1 receptor

In Australia, report concerns to the TGA for safety tracking

Dig Liver Dis 2016

Safety practices that strengthen research quality Good safety practice in peptide research is mostly disciplined observation

improves with slower dose escalation Vomiting, diarrhea, or constipation Bloating, heartburn, or stomach discomfort Reduced appetite and early fullness Fatigue or headache Less common side effects Injection-site reactions Fatigue or changes in taste Temporary mild hair thinning (limited evidence) Serious but rare risks Pancreatitis seek care immediately if you experience severe abdominal pain Gallbladder disease or gallstones Kidney complications, particularly from dehydration Thyroid C-cell tumor risk in patients with medullary thyroid cancer history or MEN2 Low blood sugar when combined with insulin or sulfonylureas Contact your provider immediately if you experience severe or persistent abdominal pain, constant vomiting, signs of dehydration, yellowing of the skin or eyes, or symptoms of low blood sugar

5 (17) (2020) D.J

Sep-Oct 2021;42(5):102640